FDLI Pharmaceutical Update
Executive Summary
Agenda topics for FDLI's May 30-31 meeting include OTC advertising, approvals and enforcement and direct-to-consumer advertising of Rx drugs. Speakers include FDA Drug Labeling Compliance Div. Director Rudolph Apodaca, and FDA Office of Drug Standards Director Peter Rheinstein. Conference will be at D.C. Shoreham Hotel.